NEXOGEN INC
Medtech · Private
Point-of-care molecular diagnostic device for rapid multiplexed pathogen identification in neonatal sepsis using DNA-based assays
- Grants
- $2.4M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $293K
- 2 awards · Defense, Health and Human S
- #430 of 4531 in medtech
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102012201420162018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I (A102-118-0694) | $69,478 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf - "universal Modular Sample Preparation Device" | $224,017 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | $218,289 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | $218,289 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | $983,596 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | $494,099 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | $489,497 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 427 | Koronis Biomedical Technologies Corp. | $296K | — |
| 428 | ACOUSTICABIO, INC. | $295K | — |
| 429 | EIGEN HEALTH SERVICES LLC | $294K | — |
| 430 | NEXOGEN INC | $293K | — |
| 431 | MICROBPLEX, INC. | $289K | — |
| 432 | BDYWR, LLC | $275K | — |
| 433 | JBS SCIENCE INC | $274K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Microfluidic System Based On Active Control Of Flow Resistance In Microfluidic Channels And Methods Of Use Thereofgranted
- System For Combined Electric, Magnetic, And Convective Acceleration Of Chemical And Biochemical Reactions And Methods Of Use Thereofapplication
- System For Combined Electric, Magnetic, And Convective Acceleration Of Chemical And Biochemical Reactions And Methods Of Use Thereofapplication
- Microfluidic System Based On Active Control Of Flow Resistance In Microfluidic Channels And Methods Of Use Thereofapplication
- System For Combined Electric, Magnetic And Convective Acceleration Of Chemical And Biochemical Reactions And Method Of Use Thereofapplication
- Microfluidic System Based On Active Control Of Flow Resistance In Microfluidic Channels And Method Of Use Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.